¢Â Topic : Nanomedical Technology in Personalized Cancer Medicine Seminar
¢Â Speaker : Çã ¿ë ¹Î ±³¼ö(¿¬¼¼´ë ÀÇ´ë ¿µ»óÀÇÇаú)
¢Â Date/Time : 2010. 03. 02. 3:00PM
¢Â Place : »ý¸í°øÇבּ¸¼¾ÅÍ ´ë°´ç
¢Â Information : ÀÌ Áß È¯(¾ÐŸ¸Ó»ç¾÷´Ü) 279-0882
¢Â Abstract
In designing the personalized cancer therapies (PCT), target contents are most important in cataloguing patient subgroups and evaluating targeted anticancer drug efficacy as well as its resistance. In vitro measurement of target contents can be used in optimizing personalized cancer medicine. Furthermore, in vivo understanding of target molecules via molecular imaging with nanoprobe is crucial to assessment of indication for targeted drug and monitoring its efficacy in patients, which are the key factors in planning PCT. Thus it is very important to develop useful in vivo and in vitro diagnostic tools to detect multiple targets and/or signaling pathways of cancer for realization of effective PCT. In this seminar, I will describe our recent efforts in establishing the necessary in vivo and in vitro diagnostic tools for powerful PCT.